Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherPerspective

P-Glycoprotein—a Clinical Target in Drug-Refractory Epilepsy?

Robert W. Robey, Alberto Lazarowski and Susan E. Bates
Molecular Pharmacology May 2008, 73 (5) 1343-1346; DOI: https://doi.org/10.1124/mol.108.046680
Robert W. Robey
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (R.W.R., S.E.B.); and Clinical Biochemistry Department, School of Pharmacy and Biochemistry (A.L.) and E. de Robertis Neuroscience Research Institute (A.L.), University of Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Lazarowski
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (R.W.R., S.E.B.); and Clinical Biochemistry Department, School of Pharmacy and Biochemistry (A.L.) and E. de Robertis Neuroscience Research Institute (A.L.), University of Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan E. Bates
Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (R.W.R., S.E.B.); and Clinical Biochemistry Department, School of Pharmacy and Biochemistry (A.L.) and E. de Robertis Neuroscience Research Institute (A.L.), University of Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 73 no. 5 1343-1346
DOI 
https://doi.org/10.1124/mol.108.046680
PubMed 
18314494

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received February 25, 2008
  • Accepted February 26, 2008
  • Published online April 16, 2008.

Article Versions

  • Earlier version (February 26, 2008 - 13:11).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Robert W. Robey,
  2. Alberto Lazarowski, and
  3. Susan E. Bates
  1. Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (R.W.R., S.E.B.); and Clinical Biochemistry Department, School of Pharmacy and Biochemistry (A.L.) and E. de Robertis Neuroscience Research Institute (A.L.), University of Buenos Aires, Argentina
  1. Address correspondence to:
    Robert W. Robey, 9000 Rockville Pike, Bldg 10 Rm 12C217, Bethesda, MD 20892. robeyr{at}mail.nih.gov
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2008 to November 2023

AbstractFullPdf
Feb 200840026
Mar 2008300224
Apr 20089633122
May 2008743069
Jun 2008433445
Jul 2008521631
Aug 2008391422
Sep 2008531018
Oct 2008411725
Nov 2008291524
Dec 2008262727
Jan 2009251218
Feb 2009491429
Mar 2009391123
Apr 200921921
May 2009122724
Jun 200961733
Jul 2009232637
Aug 2009102323
Sep 2009162531
Oct 2009162329
Nov 200993134
Dec 2009211726
Jan 2010553356
Feb 2010382241
Mar 2010292025
Apr 2010253229
May 2010293529
Jun 2010172618
Jul 2010142430
Aug 2010312426
Sep 2010241929
Oct 2010193942
Nov 2010142127
Dec 201092230
Jan 2011211425
Feb 2011151022
Mar 2011231823
Apr 201192324
May 2011272335
Jun 201115516
Jul 2011161421
Aug 2011231723
Sep 2011243121
Oct 2011323036
Nov 2011222738
Dec 2011203736
Jan 2012311829
Feb 2012142633
Mar 2012313141
Apr 2012203149
May 2012213129
Jun 2012153027
Jul 2012282946
Aug 2012212423
Sep 2012211022
Oct 2012221322
Nov 2012242826
Dec 2012122317
Jan 2013132521
Feb 201392314
Mar 2013251920
Apr 2013342227
May 2013222624
Jun 2013895
Jul 2013172010
Aug 201316147
Sep 20132138
Oct 2013896
Nov 2013151010
Dec 2013969
Jan 201424118
Feb 201415108
Mar 201418912
Apr 201412138
May 2014101212
Jun 20141189
Jul 201481515
Aug 20144167
Sep 201412714
Oct 201414138
Nov 201415133
Dec 201414103
Jan 20157198
Feb 201512176
Mar 20151376
Apr 201510116
May 2015141615
Jun 20154125
Jul 20158135
Aug 201512198
Sep 20151293
Oct 20151668
Nov 20157119
Dec 201531510
Jan 2016161712
Feb 2016211515
Mar 201610412
Apr 20165610
May 2016588
Jun 2016121213
Jul 201613125
Aug 201611169
Sep 201618195
Oct 201631718
Nov 20162145
Dec 20162175
Jan 20172259
Feb 20171256
Mar 201702911
Apr 201701610
May 20170144
Jun 20170254
Jul 201721518
Aug 201712118
Sep 201701931
Oct 201722526
Nov 201701818
Dec 201703018
Jan 20180217
Feb 201802212
Mar 201822814
Apr 201813019
May 201802128
Jun 201811515
Jul 201802332
Aug 201801011
Sep 2018078
Oct 20180168
Nov 20180921
Dec 201815411
Jan 2019401
Feb 2019922
Mar 20191111
Apr 20191136
May 20191403
Jun 2019905
Jul 20191501
Aug 20192123
Sep 20191606
Oct 20191312
Nov 20193104
Dec 20191200
Jan 20201803
Feb 20201412
Mar 2020310
Apr 20201401
May 20201111
Jun 20201002
Jul 2020833
Aug 2020502
Sep 20201421
Oct 20201402
Nov 2020822
Dec 20201713
Jan 20211124
Feb 2021913
Mar 20212711
Apr 20211210
May 2021732
Jun 2021911
Jul 20211111
Aug 2021712
Sep 2021420
Oct 2021600
Nov 20211112
Dec 20211521
Jan 202231812
Feb 20221320
Mar 20221521
Apr 20221121
May 20221224
Jun 20221210
Jul 2022712
Aug 20222334
Sep 20222302
Oct 20221743
Nov 2022915
Dec 20221110
Jan 2023321
Feb 20231222
Mar 20231111
Apr 20232316
May 20231624
Jun 2023910
Jul 20231329
Aug 2023756
Sep 2023621
Oct 20231623
Nov 20231625

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 73 (5)
Molecular Pharmacology
Vol. 73, Issue 5
1 May 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
P-Glycoprotein—a Clinical Target in Drug-Refractory Epilepsy?
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherPerspective

P-Glycoprotein—a Clinical Target in Drug-Refractory Epilepsy?

Robert W. Robey, Alberto Lazarowski and Susan E. Bates
Molecular Pharmacology May 1, 2008, 73 (5) 1343-1346; DOI: https://doi.org/10.1124/mol.108.046680

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherPerspective

P-Glycoprotein—a Clinical Target in Drug-Refractory Epilepsy?

Robert W. Robey, Alberto Lazarowski and Susan E. Bates
Molecular Pharmacology May 1, 2008, 73 (5) 1343-1346; DOI: https://doi.org/10.1124/mol.108.046680
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Coronavirus in the Brain and the Impact of Smoking
  • G Protein Signaling Then and Now: A Tribute to Al Gilman
  • Cellular Assays Detect Pluridimensional and Biased Efficacy
Show more PERSPECTIVES

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics